Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry
Go back to Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry| (NASDAQ: INBS) | Delayed: 2.15 -0.08 (3.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.23 | 52 Week High | $ | |||
| Open | $2.25 | 52 Week Low | $ | |||
| Day High | $2.29 | P/E | N/A | |||
| Day Low | $2.13 | EPS | $ | |||
| Volume | 69,756 | |||||
| (NASDAQ: INBS) | Delayed: 2.15 -0.08 (3.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.23 | 52 Week High | $ | |||
| Open | $2.25 | 52 Week Low | $ | |||
| Day High | $2.29 | P/E | N/A | |||
| Day Low | $2.13 | EPS | $ | |||
| Volume | 69,756 | |||||

